Snowball logo
logo
J7Z

JAZZ PHARMACEUTICAL (J7Z.SG)

€184.65€0.00  (0%)
Estimate
P/E
14.8
EPS
12.51
Beta
0.324
Growth
Revenue, YoY
18.64%
Net income, YoY
127.55%
FCF, YoY
229.26%
About the company
Ticker
J7Z
ISIN
IE00B4Q5ZN47
Country
Other
Sector (GICS)
Materials
There is no Profile data available for J7Z.SG.

Frequently asked questions

What sector does JAZZ PHARMACEUTICAL (J7Z.SG) (J7Z) operate in?

JAZZ PHARMACEUTICAL (J7Z.SG) belongs to the Materials sector and operates in the Other industry.

What is JAZZ PHARMACEUTICAL (J7Z.SG) (J7Z) current stock price?

As of the latest data, JAZZ PHARMACEUTICAL (J7Z.SG) stock price is €184.65, with a previous close of €184.65.

What is JAZZ PHARMACEUTICAL (J7Z.SG) (J7Z) Earnings Per Share (EPS)?

The trailing EPS is €12.51.

What is JAZZ PHARMACEUTICAL (J7Z.SG) (J7Z) Price-to-Earnings (P/E) ratio?

JAZZ PHARMACEUTICAL (J7Z.SG) current P/E ratio is 14.76.

What is JAZZ PHARMACEUTICAL (J7Z.SG) (J7Z) EBITDA?

JAZZ PHARMACEUTICAL (J7Z.SG) EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 374.01 million.

Does JAZZ PHARMACEUTICAL (J7Z.SG) (J7Z) pay dividends?

No. JAZZ PHARMACEUTICAL (J7Z.SG) does not pay a dividend.

When is JAZZ PHARMACEUTICAL (J7Z.SG) (J7Z) next earnings report?

JAZZ PHARMACEUTICAL (J7Z.SG) is expected to release its next earnings report on September 30, 2026.

What is JAZZ PHARMACEUTICAL (J7Z.SG) (J7Z) beta (volatility) score?

JAZZ PHARMACEUTICAL (J7Z.SG) has a beta of 0.324, indicating lower volatility than the overall market.